HR 5435
117th Congress
House
Health
Advisory bodies
Department of Health and Human Services
Drug therapy
Executive agency funding and structure
Food and Drug Administration (FDA)
Medical research
Neurological disorders
Scientific communication
BRAIN Act of 2021
Introduced: September 30, 2021
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 1, 2021
Referred to the Subcommittee on Health.
Sep 30, 2021
Referred to the House Committee on Energy and Commerce.
Sep 30, 2021
Sponsor introductory remarks on measure. (CR E1050)
Sep 30, 2021
Introduced in House
Plain-English summary
Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021
This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.
The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.
The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2